Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, Alice Lee, Aimee M. Near, Penelope M. Webb, Christina M. Nagle, Jennifer A. Doherty, Kara L Cushing-Haugen, Kristine G. Wicklund, Jenny Chang-Claude, Rebecca Hein, Galina Lurie, Lynne R. Wilkens, Michael E. Carney, Marc T. Goodman, Kirsten Moysich, Susanne K Kjaer, Estrid Hogdall, Allan Jensen, Ellen L. Goode, Brooke L. Fridley, Melissa C. Larson, Joellen M. Schildkraut, Rachel T. Palmieri, Daniel W. Cramer, Kathryn L. Terry, Allison F. Vitonis, Linda J Titus, Argyrios Ziogas, Wendy Brewster, Hoda Anton-Culver, Alexandra Gentry-Maharaj, Susan J. Ramus, A Rebecca Anderson, Doerthe Brueggmann, Peter A. Fasching, Simon A. Gayther, David G. Huntsman, Usha Menon, Roberta B. Ness, Malcolm C. Pike, Harvey Risch, Anna H. Wu, Andrew Berchuck
The Lancet. Oncology · 2012 · doi:10.1016/s1470-2045(11)70404-1
journal-article OA: hybrid CC0
🔓 Open OA copy View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This pooled analysis of case–control studies investigated the association between endometriosis and the risk of specific histological subtypes of ovarian cancer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BackgroundEndometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer.MethodsData from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models.Findings13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45).InterpretationClinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer.FundingOvarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.

My notes (saved in your browser only)

Condition tags

endometriosis

Funding

funders
[{'doi': '10.13039/100004802', 'name': 'California Breast Cancer Research Program', 'awards': ['0001389V20170']}, {'doi': '10.13039/100004802', 'name': 'California Breast Cancer Research Program', 'awards': ['2110200']}, {'doi': '10.13039/501100004963', 'name': 'Seventh Framework Programme', 'awards': ['HEALTH-F2-2009-223175']}, {'doi': '10.13039/501100009020', 'name': 'University of South China', 'awards': []}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['5R01 CA074850']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['CA14089']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['CA17054']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['CA58860']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['CA61132']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['CA92044']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['N01 CN67001']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['N01 PC35137']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['N01 PC67010']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['P50 CA105009']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['P50 CA136393']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['PSA 042205']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA112523']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA122443']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA126841']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA136891']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA54419']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA58598']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA61107']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA76016']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA87538']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R01 CA95023']}, {'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R03 CA113148']}, {'doi': '10.13039/100000182', 'name': 'Medical Research and Materiel Command', 'awards': ['DAMD 170110729']}, {'doi': '10.13039/100000182', 'name': 'Medical Research and Materiel Command', 'awards': ['DAMD17-02-1-0669']}, {'doi': '10.13039/100000182', 'name': 'Medical Research and Materiel Command', 'awards': ['W81XWH0610220']}, {'doi': '10.13039/100000182', 'name': 'Medical Research and Materiel Command', 'awards': ['W81XWH1010280']}, {'doi': '10.13039/100001275', 'name': 'Oak Foundation', 'awards': []}, {'doi': '10.13039/100020156', 'name': 'Lon V. Smith Foundation', 'awards': ['LVS 39420']}, {'doi': '10.13039/100005002', 'name': 'California Department of Public Health', 'awards': ['050E8709']}, {'doi': '10.13039/100006398', 'name': 'Roswell Park Alliance Foundation, Roswell Park Cancer Institute', 'awards': []}, {'doi': '10.13039/100008363', 'name': 'Kræftens Bekæmpelse', 'awards': []}, {'doi': '10.13039/100008658', 'name': 'Deutsches Krebsforschungszentrum', 'awards': []}, {'doi': '10.13039/501100000925', 'name': 'National Health and Medical Research Council', 'awards': ['199600']}, {'doi': '10.13039/501100001169', 'name': 'Cancer Council Tasmania', 'awards': []}, {'doi': '10.13039/501100002724', 'name': 'American University of Sharjah', 'awards': []}]

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (40)

Cited by (6)

Source provenance

crossref
last seen: 2026-05-19T01:00:25.614172+00:00
unpaywall
last seen: 2026-05-19T02:00:00.852167+00:00
License: CC0 · commercial use OK